Skip to main content
. Author manuscript; available in PMC: 2020 Mar 30.
Published in final edited form as: Biomed Pharmacother. 2019 Jul 1;117:109168. doi: 10.1016/j.biopha.2019.109168

Fig. 6.

Fig. 6.

42-year-old Woman Receiving Immunotherapy for Metastatic Melanoma.

A, Maximum intensity projection image from an 18F-FDG PET/CT demonstrates diffuse hypermetabolic activity in the colon (arrows) and diffuse uptake involving the pancreas (arrowhead).

B, Coronal PET images show diffuse uptake throughout the entire colon consistent with colitis (arrows), an adverse effect related to immunotherapy. </p/> C, Axial fused PET/CT show diffuse uptake throughout the pancreas (arrowheads) consistent with pancreatitis related to immunotherapy.